<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>27</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Aline Jacques</style></author><author><style face="normal" font="default" size="100%">Ingrid Ruthy</style></author><author><style face="normal" font="default" size="100%">Patrick Maggi</style></author><author><style face="normal" font="default" size="100%">Suzanne Remy</style></author><author><style face="normal" font="default" size="100%">Perrine Hoet</style></author><author><style face="normal" font="default" size="100%">Haufroid, Vincent</style></author><author><style face="normal" font="default" size="100%">Pirard, Catherine</style></author><author><style face="normal" font="default" size="100%">Charlier, Corinne</style></author><author><style face="normal" font="default" size="100%">Heidi Demaegdt</style></author><author><style face="normal" font="default" size="100%">Karlien Cheyns</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">BIOMONITORING HUMAIN WALLON BMH-WAL DÉTERMINATION DES VALEURS DE RÉFÉRENCE POUR LA POPULATION WALLONNE PHASE 1 : NOUVEAU-NÉS, ADOLESCENTS ET ADULTES 20-39 ANS SUBSTANCES SUPPLÉMENTAIRES</style></title></titles><dates><year><style  face="normal" font="default" size="100%">2023</style></year><pub-dates><date><style  face="normal" font="default" size="100%">24/03/2023</style></date></pub-dates></dates><pages><style face="normal" font="default" size="100%">54</style></pages><language><style face="normal" font="default" size="100%">eng</style></language></record></records></xml>